Cytoprotective Effect of NC-1300-O-3 against Gastric Lesions Induced by Necrotizing Agents in Rats.
スポンサーリンク
概要
- 論文の詳細を見る
The cytoprotective effect of NC-1300-O-3 and its mechanism of action were investigated. NC-1300-O-3 at doses of 3 and 10 mg/kg, p.o. significantly prevented the formation of gastric lesions by HCl-ethanol in rats, and its efficacy was not influenced by repeated administration for up to 4 weeks. The interaction between NC-1300-O-3 and necrotizing agents in the stomach, which is considered to be related to the development of cytoprotection, was not observed. A preventive effect of NC-1300-O-3 against gastric lesions was observed at the same dose even when gastric secretion was completely inhibited by pretreatment with omeprazole. This suggests that the cytoprotective effect of NC-1300-O-3 is an action on the gastric mucosa independent of its antisecretory effect. The cytoprotective effect of NC-1300-0-3 was not affected by pretreatment with indomethacin but was partly decreased by <I>N</I>-ethylmaleimide pretreatment, suggesting the participation of endogenous sulfhydryl compounds in the action of NC-1300-O-3. This compound dose-dependently increased the hexosamine content in the gastric lumen in rats at a dose range of 3-30 mg/kg, p.o. and slightly inhibited a reduction in surface mucus and mucosal hexosamine content caused by necrotizing agents. Moreover, NC-1300-O-3 at doses of 10 and 30 mg/kg, p.o. significantly inhibited the increased gastric vascular permeability caused by alcohol treatment; and at 30 mg/kg, p.o., it inhibited the reduction in potential difference caused by aspirin in rats. These actions were suggested to contribute to the cytoprotective effect of NC-1300-O-3.
- 公益社団法人 日本薬理学会の論文
著者
-
Uchida Aoi
Research Laboratories Nippon Chemiphar Co. Ltd.
-
Kamishiro Toshiro
Research Laboratories, Nippon Chemiphar Co., Ltd.
-
Matsukura Hitoshi
Research Laboratories, Nippon Chemiphar Co., Ltd.
-
Masuda Makoto
Research Laboratories, Nippon Chemiphar Co., Ltd.
-
Kawaguchi Kazuhiko
Research Laboratories, Nippon Chemiphar Co., Ltd.
関連論文
- Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors
- Cytoprotective Effect of NC-1300-O-3 against Gastric Lesions Induced by Necrotizing Agents in Rats.
- Effects of NC-1300-O-3 on Gastric Mucus Secretion and Prostaglandin Release in Rats.